Evidence map›Paper›PMID 40989508›Full record

ReviewRSC advances2025

Metal-organic frameworks for biomedical applications: bridging materials science and regenerative medicine.

Negar Nasri, Marziyeh Azad, Zahra Mehrabi, Ghasem Dini, Afsaneh Marandi

Abstract readReview
In one paragraph

Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Contrast Agents for Enhanced Bioimaging: A Comprehensive Review.Chembiochem : a European journal of chemical biology · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Negar NasriDepartment of Life Science Engineering, Faculty of Modern Science and Technology, Nano Biotechnology Group, University of Tehran Tehran 1439957131 Iran.ORCID https://orcid.org/0000-0003-2845-6424
Marziyeh AzadDepartment of Nanotechnology, Faculty of Chemistry, University of Isfahan Isfahan 81746-73441 Iran g.dini@sci.ui.ac.ir +9837932700 +9837934914.ORCID https://orcid.org/0009-0008-9041-8545
Zahra MehrabiDepartment of Biotechnology, Faculty of Biological Science and Technology, University of Isfahan Isfahan 81746-73441 Iran.ORCID https://orcid.org/0009-0004-5325-3383
Ghasem DiniDepartment of Nanotechnology, Faculty of Chemistry, University of Isfahan Isfahan 81746-73441 Iran g.dini@sci.ui.ac.ir +9837932700 +9837934914.ORCID https://orcid.org/0000-0002-0405-8424
Afsaneh MarandiDepartment of Chemistry, Catalysis Division, University of Isfahan Isfahan 81746-73441 Iran.ORCID https://orcid.org/0000-0001-7599-7771

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review explores the biomedical applications of metal-organic frameworks (MOFs), focusing on their potential in bone regeneration. Due to their high porosity, tunable structures, and biocompatibility, MOFs have emerged as promising candidates for bone tissue engineering. This article discusses the synthesis and functionalization of MOFs at the micro- and nanoscale, their interactions with biological environments, and their roles in drug delivery, osteoinduction, and osteoconduction. Recent advancements in theranostic MOF-based scaffolds, which integrate both therapeutic and diagnostic functions, are also highlighted. By mimicking the natural bone architecture, these smart scaffolds promote ossification and angiogenesis while enabling targeted therapy and precision imaging. Despite their great potential, challenges such as metal toxicity, stability, and clinical translation remain. This review emphasizes the transformative role of MOFs in regenerative medicine and discusses strategies to overcome these limitations for future clinical applications.

Identifiers

PMID40989508
PMCPMC12451528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.